393 related articles for article (PubMed ID: 11020392)
1. Hydrochlorothiazide reduces loss of cortical bone in normal postmenopausal women: a randomized controlled trial.
Reid IR; Ames RW; Orr-Walker BJ; Clearwater JM; Horne AM; Evans MC; Murray MA; McNeil AR; Gamble GD
Am J Med; 2000 Oct; 109(5):362-70. PubMed ID: 11020392
[TBL] [Abstract][Full Text] [Related]
2. The effect of treatment with a thiazide diuretic for 4 years on bone density in normal postmenopausal women.
Bolland MJ; Ames RW; Horne AM; Orr-Walker BJ; Gamble GD; Reid IR
Osteoporos Int; 2007 Apr; 18(4):479-86. PubMed ID: 17120180
[TBL] [Abstract][Full Text] [Related]
3. Low-dose hydrochlorothiazide and preservation of bone mineral density in older adults. A randomized, double-blind, placebo-controlled trial.
LaCroix AZ; Ott SM; Ichikawa L; Scholes D; Barlow WE
Ann Intern Med; 2000 Oct; 133(7):516-26. PubMed ID: 11015164
[TBL] [Abstract][Full Text] [Related]
4. Relationship Between Changes in Serum Urate and Bone Mineral Density During Treatment with Thiazide Diuretics: Secondary Analysis from a Randomized Controlled Trial.
Dalbeth N; Gamble GD; Horne A; Reid IR
Calcif Tissue Int; 2016 May; 98(5):474-8. PubMed ID: 26713333
[TBL] [Abstract][Full Text] [Related]
5. The effect of the antiestrogen tamoxifen on bone mineral density in normal late postmenopausal women.
Grey AB; Stapleton JP; Evans MC; Tatnell MA; Ames RW; Reid IR
Am J Med; 1995 Dec; 99(6):636-41. PubMed ID: 7503087
[TBL] [Abstract][Full Text] [Related]
6. Oral daily ibandronate prevents bone loss in early postmenopausal women without osteoporosis.
McClung MR; Wasnich RD; Recker R; Cauley JA; Chesnut CH; Ensrud KE; Burdeska A; Mills T;
J Bone Miner Res; 2004 Jan; 19(1):11-8. PubMed ID: 14753731
[TBL] [Abstract][Full Text] [Related]
7. Bone mineral density changes in hypercalciuretic osteoporotic men treated with thiazide diuretics.
Legroux-Gerot I; Catanzariti L; Marchandise X; Duquesnoy B; Cortet B
Joint Bone Spine; 2004 Jan; 71(1):51-5. PubMed ID: 14769521
[TBL] [Abstract][Full Text] [Related]
8. Bone density and structure in healthy postmenopausal women treated with exemestane for the primary prevention of breast cancer: a nested substudy of the MAP.3 randomised controlled trial.
Cheung AM; Tile L; Cardew S; Pruthi S; Robbins J; Tomlinson G; Kapral MK; Khosla S; Majumdar S; Erlandson M; Scher J; Hu H; Demaras A; Lickley L; Bordeleau L; Elser C; Ingle J; Richardson H; Goss PE
Lancet Oncol; 2012 Mar; 13(3):275-84. PubMed ID: 22318095
[TBL] [Abstract][Full Text] [Related]
9. Soymilk or progesterone for prevention of bone loss--a 2 year randomized, placebo-controlled trial.
Lydeking-Olsen E; Beck-Jensen JE; Setchell KD; Holm-Jensen T
Eur J Nutr; 2004 Aug; 43(4):246-57. PubMed ID: 15309425
[TBL] [Abstract][Full Text] [Related]
10. Combination treatment with estrogen and calcitriol in the prevention of age-related bone loss.
Gallagher JC; Fowler SE; Detter JR; Sherman SS
J Clin Endocrinol Metab; 2001 Aug; 86(8):3618-28. PubMed ID: 11502787
[TBL] [Abstract][Full Text] [Related]
11. Effects of hormone replacement therapy on bone mineral density in postmenopausal women with primary hyperparathyroidism: four-year follow-up and comparison with healthy postmenopausal women.
Orr-Walker BJ; Evans MC; Clearwater JM; Horne A; Grey AB; Reid IR
Arch Intern Med; 2000 Jul; 160(14):2161-6. PubMed ID: 10904459
[TBL] [Abstract][Full Text] [Related]
12. Effect of hormone replacement therapy on bone mineral density in postmenopausal women with mild primary hyperparathyroidism. A randomized, controlled trial.
Grey AB; Stapleton JP; Evans MC; Tatnell MA; Reid IR
Ann Intern Med; 1996 Sep; 125(5):360-8. PubMed ID: 8702086
[TBL] [Abstract][Full Text] [Related]
13. Long-term effects of calcium supplementation on bone loss and fractures in postmenopausal women: a randomized controlled trial.
Reid IR; Ames RW; Evans MC; Gamble GD; Sharpe SJ
Am J Med; 1995 Apr; 98(4):331-5. PubMed ID: 7709944
[TBL] [Abstract][Full Text] [Related]
14. Bone density in women receiving depot medroxyprogesterone acetate for contraception.
Cundy T; Evans M; Roberts H; Wattie D; Ames R; Reid IR
BMJ; 1991 Jul; 303(6793):13-6. PubMed ID: 1830502
[TBL] [Abstract][Full Text] [Related]
15. Prevention of bone loss by clodronate in early postmenopausal women with vertebral osteopenia: a dose-finding study.
Välimäki MJ; Laitinen K; Patronen A; Puolijoki H; Seppänen J; Pylkkänen L; Aranko SM; Sairanen S; Blåfield H; Rekiaro M; Väisänen K; Kormano M; Mäkinen L; Salmi J; Ala-Kaila K; Perttilä J; Vesterinen K; Koivunoro K;
Osteoporos Int; 2002 Dec; 13(12):937-47. PubMed ID: 12459936
[TBL] [Abstract][Full Text] [Related]
16. A dose-ranging trial of a matrix transdermal 17beta-estradiol for the prevention of bone loss in early postmenopausal women. International Study Group.
Delmas PD; Pornel B; Felsenberg D; Garnero P; Hardy P; Pilate C; Dain MP
Bone; 1999 May; 24(5):517-23. PubMed ID: 10321913
[TBL] [Abstract][Full Text] [Related]
17. Thiazides and bone.
Sebastian A
Am J Med; 2000 Oct; 109(5):429-30. PubMed ID: 11020400
[No Abstract] [Full Text] [Related]
18. Tamoxifen reduces bone turnover and prevents lumbar spine and proximal femoral bone loss in early postmenopausal women.
Ward RL; Morgan G; Dalley D; Kelly PJ
Bone Miner; 1993 Aug; 22(2):87-94. PubMed ID: 8251768
[TBL] [Abstract][Full Text] [Related]
19. Thiazides and seasonal bone change in healthy postmenopausal women.
Dawson-Hughes B; Harris S
Bone Miner; 1993 Apr; 21(1):41-51. PubMed ID: 8324419
[TBL] [Abstract][Full Text] [Related]
20. Effect of intermittent administration of 200 IU intranasal salmon calcitonin and low doses of 1alpha(OH) vitamin D3 on bone mineral density of the lumbar spine and hip region and biochemical bone markers in women with postmenopausal osteoporosis: a pilot study.
Kaskani E; Lyritis GP; Kosmidis C; Galanos A; Andypas G; Chorianopoulos K; Giagiosis A; Iliadou K; Karagianis A; Katsimichas K; Koskinas A; Matsouka K
Clin Rheumatol; 2005 Jun; 24(3):232-8. PubMed ID: 15647969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
